Evidence map›Paper›PMID 33919383›Full record

ArticleMetabolites2021

Understanding FBA Solutions under Multiple Nutrient Limitations.

Eunice van Pelt-KleinJan, Daan H de Groot, Bas Teusink

Abstract read
In one paragraph

Article in Metabolites, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Thermodynamic Evaluation of Dual Substrate Growth.Biotechnology and bioengineering · 2026
    Article
  2. Article
  3. Rational Targeting and gRNA Design for Enhancing Quorum Quenching inComputational and structural biotechnology journal · 2026
    Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Eunice van Pelt-KleinJanTiFN, P.O. Box 557, NL6700AN Wageningen, The Netherlands.ORCID 0000-0002-6590-652X
Daan H de GrootSystems Biology Lab, Amsterdam Institute of Molecular and Life Sciences, Vrije Universiteit Amsterdam, 1081HZ Amsterdam, The Netherlands.ORCID 0000-0001-7070-8950
Bas TeusinkTiFN, P.O. Box 557, NL6700AN Wageningen, The Netherlands.ORCID 0000-0003-3929-0423

Funding

Nederlandse Organisatie voor Wetenschappelijk Onderzoek 865.14.005Nederlandse Organisatie voor Wetenschappelijk Onderzoek ALWTF.2015.4
6 · The paper itself

Abstract

Genome-scale stoichiometric modeling methods, in particular Flux Balance Analysis (FBA) and variations thereof, are widely used to investigate cell metabolism and to optimize biotechnological processes. Given (1) a metabolic network, which can be reconstructed from an organism's genome sequence, and (2) constraints on reaction rates, which may be based on measured nutrient uptake rates, FBA predicts which reactions maximize an objective flux, usually the production of cell components. Although FBA solutions may accurately predict the metabolic behavior of a cell, the actual flux predictions are often hard to interpret. This is especially the case for conditions with many constraints, such as for organisms growing in rich nutrient environments: it remains unclear why a certain solution was optimal. Here, we rationalize FBA solutions by explaining for which properties the optimal combination of metabolic strategies is selected. We provide a graphical formalism in which the selection of solutions can be visualized; we illustrate how this perspective provides a glimpse of the logic that underlies genome-scale modeling by applying our formalism to models of various sizes.

Indexed as

elementary conversion modeselementary flux modesflux balance analysisgenome-scale modelingphenotype phase plane analysisstoichiometric modeling

Identifiers

PMID33919383
PMCPMC8143296

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.